Schedule 13G ownership disclosure
RxSight Inc
Common Stock · CUSIP: 78349D107
Event date: 2024-12-31
- Filing-level shares
- 1,715.00
- Percent of class
- 0.00%
- Lord, Abbett & Co. LLC
Shares: 1,715.00 · Class: 0.00%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000930413-25-000572
- Form type
- SCHEDULE 13G/A
- Filer
- LORD, ABBETT & CO. LLC
- CIK
- CIK 728100
- Filed
- Feb 13, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership